Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTaP-Hep B-PRP-T Booster Study in Filipino Toddlers
NCT00514709Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2007
- Primary completion
- Dec 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria + tetanus + acellular pertussis + hepatitis B + haemophilus influenzae type b conjugate vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by Sanofi. Started Sep 2007; status: completed.
02
Drugs
diphtheria + tetanus + acellular pertussis + hepatitis B + haemophilus influenzae type b conjugate vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00514709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514709.